Pharmacogenetics represents a significant leap toward personalized healthcare, allowing clinicians to tailor drug therapies based on individual genetic profiles. However, the successful integration of pharmacogenetics in clinical practice remains a complex challenge. A recent national survey conducted in the Netherlands investigated the experiences and attitudes of pharmacists, an expert group often understudied in this field. This research highlights the unique position of pharmacists as medication experts who can support physicians in optimizing patient care through genomic data.

The survey results indicate that pharmacists are generally confident in their knowledge and skills related to genetic testing. Interestingly, while only 44.4% of respondents had ever requested a test, a striking 88.6% had experience interpreting results. This suggests that pharmacists already play a vital role in managing genetic data, even if they are not the primary initiators of the testing process. Furthermore, most respondents maintained a positive attitude toward the technology, despite reporting several systemic hurdles.

Barriers to Pharmacogenetics in Clinical Practice

Despite these positive attitudes, several hurdles continue to impede wider adoption. Respondents identified high costs and the lack of insurance reimbursement as primary obstacles. Furthermore, a deficiency in clear, evidence-based clinical guidelines remains a significant concern. Consequently, many pharmacists maintain a cautious approach in scenarios where clinical evidence is limited. Therefore, improving interprofessional collaboration between physicians and pharmacists is essential to bridge the knowledge gap.

Updated health policies that prioritize genomic medicine could also alleviate financial barriers and streamline workflows. Similar challenges exist in India, where genetic diversity and resource limitations require tailored implementation strategies. By addressing these factors, healthcare systems can better leverage the benefits of personalized medicine. Importantly, the study concludes that expanding the evidence base and updating health policy are critical steps for the successful adoption of these technologies.

Frequently Asked Questions

What are the primary barriers to using pharmacogenetics in clinical practice?

The main barriers include high testing costs, lack of insurance coverage, and a deficiency in updated clinical guidelines. Limited provider education also plays a role in the slow adoption of these tools.

How do pharmacists contribute to pharmacogenetics?

Pharmacists provide expert knowledge in drug metabolism and pharmacokinetics. They often assist physicians in interpreting genetic test results and recommending appropriate dosage adjustments based on a patient's unique genetic profile.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

De Brabander EY et al. Knowledge and Attitudes Regarding Pharmacogenetics of Pharmacists in the Netherlands: A National Online Survey Study. J Eval Clin Pract. 2026 Mar undefined. doi: 10.1111/jep.70395. PMID: 41764771.

Abraham ER et al. Pharmacogenetics in a tertiary care center; knowledge, attitude and practice among physician and clinical pharmacist. Asian J Hosp Pharm. 2023;5(4). doi: 10.38022/ajhp.v5i4.117.

Bansal V et al. Future Challenges of Pharmacogenomics in Clinical Practice. JK Science. 2005;7(3):177-179.